The economic burden of pediatric growth hormone deficiency in Italy: a cost of illness study.
Marco CappaG PozzobonMassimiliano OrsoMohamad MaghnieGiuseppa PattiFederico SpandonaroS GranatoG NovelliD La TorreMaria Carolina SalernoBarbara PolistenaPublished in: Journal of endocrinological investigation (2024)
The total annual cost for GHD children is close to € 10,000, and is mainly due to the cost of rhGH treatment. This cost is almost entirely sustained by the NHS, with negligible out-of-pocket expenses. The economic burden on the Italian NHS for the health care of established GHD children is fourfold higher than the prevalence of the disease in the overall Italian population.